Cantel Medical Named to the Forbes 2013 List of 100 Best Small Companies in America
Cantel Medical Corp. announces that for the second consecutive year it was named to the Forbes list of the "100 Best Small Companies in America." The company was ranked No. 67 on the Forbes 2013 list.
Cantel's president and CEO, Andrew Krakauer, says, "We are pleased to have been recognized for the success the company has achieved both this year and over the past five years. I share this honor with our 1,300 hardworking and loyal employees. As a leader in the growing infection prevention and control market, the company has performed well despite the difficult economic environment. We are optimistic that Cantel is positioned for sustained growth in the future. Our entire organization has a great sense of pride in providing the products, services and the guidance to mitigate infection risks, improve safety, and ultimately help save lives."
The Forbes rankings are based on one- and five-year earnings growth, sales growth and return on equity. To qualify, companies must have sales between $5 million and $1 billion, and meet certain share price and other criteria. Forbes also considers a company's stock performance with its industry peers during the last year.
Source: Cantel Medical Corp.
Â
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Ensuring Safe Practices: Managing Surgical Instruments in the Context of Creutzfeldt-Jakob Disease
February 27th 2025Creutzfeldt-Jakob Disease (CJD) presents significant challenges for infection control. Learn best practices for safe instrument disposal, reprocessing, and compliance with CDC and WHO guidelines.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
